The global digital therapeutics market is expected to grow from US$ 4,226.94 million in 2021 to US$ 18,061.79 million by 2028; it is estimated to grow at a CAGR of 23.1% from 2021 to 2028.
The increasing prevalence of chronic diseases, the growing need to reduce healthcare costs, and partnerships and collaborations by companies fuel the demand for digital therapeutics. However, the rise in concerns related to cyber threats and data security hampers the market growth.
Digital therapeutics is a subdivision of digital health, representing a collection of technologies, products, and services across the healthcare & wellness industries. It is an evidence-based therapeutic intervention for patients driven by software to prevent, manage, or treat a medical disorder or disease, such as congestive heart failure, obesity, dementia, type 2 diabetes, asthma, ADHD, hypertension, and anxiety. They are used to improve patient care and health outcomes, either independently or with medications and devices. Due to the digital nature of the methodology, data can be collected and analyzed as a progress report and a preventative measure. Digital therapeutics often employ strategies rooted in cognitive behavioral therapy. Digital therapeutic products are reviewed and approved by regulators to augment product claims on risk, efficacy, and intended use.
Digital therapeutics gained rapid acceptance from employers and insurance providers owing to its benefits. The market has a significant number of small players; however, large companies have begun investing in the market in the last few years. In June 2018, Cigna collaborated with Omada Health. Through this collaboration, eligible Cigna-administered health plan customers can access to Omada’s digital intensive behavioral counseling platform as a fully covered preventive benefit in health improvement program portfolio without any cost. In 2019, Propeller Health, a leading digital therapeutics company, partnered with Orion Corporation to connect the latter’s Easyhaler line of inhalers for asthma and COPD patients to Propeller’s digital medicine platform. This platform covers more than 90% of inhalable medicines for asthma and COPD. The partnership expanded Propeller’s presence in Europe. Digital Therapeutics Alliance (DTA), a nonprofit trade association of industry players and participants engaged in advancing digital therapeutics, has continued to operate in the US since 2017. The association actively drives the digital therapeutics industry's growth through collaborations and partnerships. In May 2018, DTA announced a partnership with USP, a nonprofit organization headquartered in Rockville, Maryland, to develop appropriate standards and guidelines for digital therapeutics. In October 2018, DTA expanded its European membership by joining S3 Connected Health, specializing in designing and developing digital therapeutics and health solutions.
Based on distribution channel, the digital therapeutics market is segmented into patients, providers, payers, and employers. The patients segment held the largest share of the market in 2021. However, the providers segment is anticipated to register the highest CAGR in the market during the forecast period.
A few of the primary and secondary sources referred to while preparing the report on the digital therapeutics market are the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), the International Diabetes Federation (IDF), and the American Diabetes Association.
Reasons to Buy
The increasing prevalence of chronic diseases, the growing need to reduce healthcare costs, and partnerships and collaborations by companies fuel the demand for digital therapeutics. However, the rise in concerns related to cyber threats and data security hampers the market growth.
Digital therapeutics is a subdivision of digital health, representing a collection of technologies, products, and services across the healthcare & wellness industries. It is an evidence-based therapeutic intervention for patients driven by software to prevent, manage, or treat a medical disorder or disease, such as congestive heart failure, obesity, dementia, type 2 diabetes, asthma, ADHD, hypertension, and anxiety. They are used to improve patient care and health outcomes, either independently or with medications and devices. Due to the digital nature of the methodology, data can be collected and analyzed as a progress report and a preventative measure. Digital therapeutics often employ strategies rooted in cognitive behavioral therapy. Digital therapeutic products are reviewed and approved by regulators to augment product claims on risk, efficacy, and intended use.
Digital therapeutics gained rapid acceptance from employers and insurance providers owing to its benefits. The market has a significant number of small players; however, large companies have begun investing in the market in the last few years. In June 2018, Cigna collaborated with Omada Health. Through this collaboration, eligible Cigna-administered health plan customers can access to Omada’s digital intensive behavioral counseling platform as a fully covered preventive benefit in health improvement program portfolio without any cost. In 2019, Propeller Health, a leading digital therapeutics company, partnered with Orion Corporation to connect the latter’s Easyhaler line of inhalers for asthma and COPD patients to Propeller’s digital medicine platform. This platform covers more than 90% of inhalable medicines for asthma and COPD. The partnership expanded Propeller’s presence in Europe. Digital Therapeutics Alliance (DTA), a nonprofit trade association of industry players and participants engaged in advancing digital therapeutics, has continued to operate in the US since 2017. The association actively drives the digital therapeutics industry's growth through collaborations and partnerships. In May 2018, DTA announced a partnership with USP, a nonprofit organization headquartered in Rockville, Maryland, to develop appropriate standards and guidelines for digital therapeutics. In October 2018, DTA expanded its European membership by joining S3 Connected Health, specializing in designing and developing digital therapeutics and health solutions.
Based on distribution channel, the digital therapeutics market is segmented into patients, providers, payers, and employers. The patients segment held the largest share of the market in 2021. However, the providers segment is anticipated to register the highest CAGR in the market during the forecast period.
A few of the primary and secondary sources referred to while preparing the report on the digital therapeutics market are the World Health Organization (WHO), the Centers for Disease Control and Prevention (CDC), the International Diabetes Federation (IDF), and the American Diabetes Association.
Reasons to Buy
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the digital therapeutics market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global digital therapeutics market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
Table of Contents
1. Introduction1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Digital Therapeutics Market - By Application
1.3.2 Digital Therapeutics Market - By Distribution Channel
1.3.3 Digital Therapeutics Market - By Geography
2. Digital Therapeutics Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Digital Therapeutics Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America: PEST Analysis
4.2.2 Europe: PEST Analysis
4.2.3 Asia Pacific: PEST Analysis
4.2.4 Middle East and Africa: PEST Analysis
4.2.5 South and Central America: PEST Analysis
4.3 Expert Opinion
5. Digital Therapeutics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Chronic Diseases
5.1.2 Concerns Regarding Need to Reduce Healthcare Costs
5.1.3 Partnerships and Collaborations by Companies
5.2 Market Restraints
5.2.1 Cyber Threat and Rise in Data Security
5.3 Market Opportunities
5.3.1 Large Population with Undiagnosed Conditions
5.4 Future Trends
5.4.1 Increasing Number of Start-Ups
5.5 Impact analysis
6. Digital Therapeutics Market - Global Analysis
6.1 Global Digital Therapeutics Market Revenue Forecast and Analysis
6.2 Global Digital Therapeutics Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Digital Therapeutics Market Analysis - By Application
7.1 Overview
7.2 Digital Therapeutics Market Revenue Share, by Application (2021 and 2028)
7.3 Diabetes
7.3.1 Overview
7.3.2 Diabetes: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
7.3.3 Cardiovascular Disease
7.3.3.1 Overview
7.3.3.2 Cardiovascular Disease: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
7.3.4 Central Nervous System Diseases
7.3.4.1 Overview
7.3.4.2 Central Nervous System Diseases: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
7.3.5 Respiratory Diseases
7.3.5.1 Overview
7.3.5.2 Respiratory Diseases: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
7.3.6 Smoking Cessation
7.3.6.1 Overview
7.3.6.2 Smoking Cessation: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
7.3.7 Musculoskeletal Disorders
7.3.7.1 Overview
7.3.7.2 Musculoskeletal Disorders: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
7.3.8 Others
7.3.8.1 Overview
7.3.8.2 Others: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
8. Digital Therapeutics Market Analysis - By Distribution Channel
8.1 Overview
8.2 Digital Therapeutics Market Revenue Share, by Distribution Channel (2021 and 2028)
8.3 Patients
8.3.1 Overview
8.3.2 Patients: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Providers
8.4.1 Overview
8.4.2 Providers: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Payers
8.5.1 Overview
8.5.2 Payers: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
8.6 Employers
8.6.1 Overview
8.6.2 Employers: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
9. Digital Therapeutics Market - Geographical Analysis
9.1 North America: Digital Therapeutics Market
9.1.1 Overview
9.1.2 North America: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
9.1.3 North America: Digital Therapeutics Market, by Application, 2019-2028 (US$ Million)
9.1.4 North America: Digital Therapeutics Market, by Distribution Channel, 2019-2028 (US$ Million)
9.1.5 North America: Digital Therapeutics Market, by Country, 2021 & 2028 (%)
9.1.5.1 US: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
9.1.5.1.1 Overview
9.1.5.1.2 US: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
9.1.5.1.3 US: Digital Therapeutics Market, by Application, 2019-2028 (US$ Million)
9.1.5.1.4 US: Digital Therapeutics Market, by Distribution Channel, 2019-2028 (US$ Million)
9.1.5.2 Canada: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
9.1.5.2.1 Overview
9.1.5.2.2 Canada: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
9.1.5.2.3 Canada: Digital Therapeutics Market, by Application, 2019-2028 (US$ Million)
9.1.5.2.4 Canada: Digital Therapeutics Market, by Distribution Channel, 2019-2028 (US$ Million)
9.1.5.3 Mexico: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
9.1.5.3.1 Overview
9.1.5.3.2 Mexico: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
9.1.5.3.3 Mexico: Digital Therapeutics Market, by Application, 2019-2028 (US$ Million)
9.1.5.3.4 Mexico: Digital Therapeutics Market, by Distribution Channel, 2019-2028 (US$ Million)
9.2 Europe: Digital Therapeutics Market
9.2.1 Overview
9.2.2 Europe: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
9.2.3 Europe: Digital Therapeutics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.2.4 Europe: Digital Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
9.2.5 Europe: Digital Therapeutics Market, by Country, 2021 & 2028 (%)
9.2.5.1 Germany: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.1.1 Overview
9.2.5.1.2 Germany: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.1.3 Germany: Digital Therapeutics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.2.5.1.4 Germany: Digital Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
9.2.5.2 France: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.2.1 Overview
9.2.5.2.2 France: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.2.3 France: Digital Therapeutics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.2.5.2.4 France: Digital Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
9.2.5.3 UK: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.3.1 Overview
9.2.5.3.2 UK: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.3.3 UK: Digital Therapeutics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.2.5.3.4 UK: Digital Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
9.2.5.4 Italy: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.4.1 Overview
9.2.5.4.2 Italy: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.4.3 Italy: Digital Therapeutics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.2.5.4.4 Italy: Digital Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
9.2.5.5 Spain: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.5.1 Overview
9.2.5.5.2 Spain: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.5.3 Spain: Digital Therapeutics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.2.5.5.4 Spain: Digital Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
9.2.5.6 Rest of Europe: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.6.1 Overview
9.2.5.6.2 Rest of Europe: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
9.2.5.6.3 Rest of Europe: Digital Therapeutics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
9.2.5.6.4 Rest of Europe: Digital Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
9.3 Asia Pacific Digital Therapeutics Market Revenue and Forecasts To 2028
9.3.1 Overview
9.3.2 Asia Pacific Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
9.3.3 Asia Pacific: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)
9.3.4 Asia Pacific: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
9.3.5 Asia Pacific: Digital Therapeutics Market Revenue and Forecasts to 2028, By Country (%)
9.3.5.1 Japan: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
9.3.5.1.1 Overview
9.3.5.1.2 Japan: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
9.3.5.1.3 Japan: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)
9.3.5.1.4 Japan: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
9.3.5.2 China: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
9.3.5.2.1 Overview
9.3.5.2.2 China: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
9.3.5.2.3 China: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)
9.3.5.2.4 China: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
9.3.5.3 India Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
9.3.5.3.1 Overview
9.3.5.3.2 India: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
9.3.5.3.3 India: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)
9.3.5.3.4 India: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
9.3.5.4 South Korea: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
9.3.5.4.1 Overview
9.3.5.4.2 South Korea: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
9.3.5.4.3 South Korea: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)
9.3.5.4.4 South Korea: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
9.3.5.5 Australia: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
9.3.5.5.1 Overview
9.3.5.5.2 Australia: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
9.3.5.5.3 Australia: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)
9.3.5.5.4 Australia: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
9.3.5.6 Rest of Asia Pacific: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.6.1 Overview
9.3.5.6.2 Rest of Asia Pacific: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
9.3.5.6.3 Rest of Asia Pacific: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)
9.3.5.6.4 Rest of Asia Pacific: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
9.4 Middle East & Africa Digital Therapeutics Market Revenue and Forecasts To 2028
9.4.1 Overview
9.4.2 Middle East & Africa Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
9.4.3 Middle East & Africa: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)
9.4.4 Middle East & Africa: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
9.4.5 Middle East & Africa Digital Therapeutics Market Revenue and Forecasts to 2028, By Country (%)
9.4.5.1 UAE: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
9.4.5.1.1 Overview
9.4.5.1.2 UAE: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
9.4.5.1.3 UAE: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)
9.4.5.1.4 UAE: Digital Therapeutics Market Revenue and Forecasts To 2028, By Distribution Channel (US$ Million)
9.4.5.2 Saudi Arabia: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
9.4.5.2.1 Overview
9.4.5.2.2 Saudi Arabia: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
9.4.5.2.3 Saudi Arabia: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)
9.4.5.2.4 Saudi Arabia: Digital Therapeutics Market Revenue and Forecasts To 2028, By Distribution Channel (US$ Million)
9.4.5.3 South Africa: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
9.4.5.3.1 Overview
9.4.5.3.2 South Africa Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
9.4.5.3.3 South Africa: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)
9.4.5.3.4 South Africa: Digital Therapeutics Market Revenue and Forecasts To 2028, By Distribution Channel (US$ Million)
9.4.5.4 Rest of Middle East and Africa: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
9.4.5.4.1 Overview
9.4.5.4.2 Rest of Middle East and Africa: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
9.4.5.4.3 Rest of Middle East & Africa: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)
9.4.5.4.4 Rest of Middle East & Africa: Digital Therapeutics Market Revenue and Forecasts To 2028, By Distribution Channel (US$ Million)
9.5 South And Central America Digital Therapeutics Market Revenue and Forecasts To 2028
9.5.1 Overview
9.5.2 South and Central America Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
9.5.3 South and Central America Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)
9.5.4 South and Central America: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
9.5.5 South and Central America Digital Therapeutics Market Revenue and Forecasts to 2028, By Country (%)
9.5.5.1 Argentina Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
9.5.5.1.1 Overview
9.5.5.1.2 Argentina Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
9.5.5.1.3 Argentina: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)
9.5.5.1.4 Argentina: Digital Therapeutics Market Revenue and Forecasts To 2028, By Distribution Channel (US$ Million)
9.5.5.2 Brazil: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
9.5.5.2.1 Overview
9.5.5.2.2 Brazil: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
9.5.5.2.3 Brazil: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)
9.5.5.2.4 Brazil: Digital Therapeutics Market Revenue and Forecasts To 2028, By Distribution Channel (US$ Million)
9.5.5.3 Rest of South and Central America: Digital Therapeutics Market - Revenue and Forecast to 2028 (USD Mn)
9.5.5.3.1 Overview
9.5.5.3.2 Rest of South and Central America: Digital Therapeutics Market - Revenue and Forecast to 2028 (USD Mn)
9.5.5.3.3 Rest of South & Central America: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)
9.5.5.3.4 Rest of South & Central America: Digital Therapeutics Market Revenue and Forecasts To 2028, By Distribution Channel (US$ Million)
10. Impact of COVID-19 Pandemic on Global Digital Therapeutics Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
10.5 South and Central America: Impact Assessment of COVID-19 Pandemic
11. Digital Therapeutics Market -Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Digital Therapeutics Market, 2021-2028
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Propeller Health (ResMed)
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Canary Health
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Noom, Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 2Morrow, Inc.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Teladoc Health, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Welldoc, Inc.
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Fitbit, Inc.
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Omada Health, Inc.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 MANGO HEALTH
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Pear Therapeutics, Inc.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Happify Health
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
13. Appendix
13.1 About The Publisher
13.2 Glossary of Terms
List of Tables
Table 1. Proportion Of People Living With Undiagnosed Diabetes (20 - 79 years) Per Region, 2021
Table 2. North America Digital Therapeutics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Digital Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2028 (USD Million)
Table 4. US Digital Therapeutics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 5. US Digital Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 6. Canada: Digital Therapeutics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 7. Canada Digital Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 8. Mexico: Digital Therapeutics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 9. Mexico Digital Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 10. Europe: Digital Therapeutics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 11. Europe: Digital Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 12. Germany: Digital Therapeutics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 13. Germany: Digital Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 14. France: Digital Therapeutics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 15. France: Digital Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million).
Table 16. UK: Digital Therapeutics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 17. UK: Digital Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 18. Italy: Digital Therapeutics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 19. Italy: Digital Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 20. Spain: Digital Therapeutics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 21. Spain: Digital Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 22. Rest of Europe: Digital Therapeutics Market, by Application - Revenue and Forecast to 2028 (US$ Million)
Table 23. Rest of Europe: Digital Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2028 (US$ Million)
Table 24. Asia Pacific: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million).
Table 25. Asia Pacific: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
Table 26. Japan: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 27. Japan: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
Table 28. China: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 29. China: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
Table 30. India: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 31. India: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
Table 32. South Korea: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 33. South Korea: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
Table 34. Australia: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 35. Australia: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
Table 36. Rest of Asia Pacific: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 37. Rest of Asia Pacific: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
Table 38. Middle East & Africa: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 39. Middle East & Africa: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
Table 40. UAE: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 41. UAE: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
Table 42. Saudi Arabia: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 43. Saudi Arabia: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
Table 44. South Africa Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 45. South Africa: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
Table 46. Rest of Middle East & Africa: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 47. Rest of Middle East & Africa: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
Table 48. South and Central America Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 49. South and Central America: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
Table 50. Argentina: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 51. Argentina: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
Table 52. Brazil: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 53. Brazil: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
Table 54. Rest of South & Central America: Digital Therapeutics Market Revenue and Forecasts to 2028, By Application (US$ Million)
Table 55. Rest of South & Central America: Digital Therapeutics Market Revenue and Forecasts to 2028, By Distribution Channel (US$ Million)
Table 56. Growth Strategies in the Digital Therapeutics Market, 2021-2028
Table 57. Recent Inorganic Growth Strategies in the Digital Therapeutics Market
Table 58. Recent Organic Growth Strategies in the Digital Therapeutics Market
Table 59. Glossary of Terms, Digital Therapeutics MarketList of Figures
Figure 1. Digital Therapeutics Market Segmentation
Figure 2. Digital Therapeutics Market - By Geography
Figure 3. Digital Therapeutics Market Overview
Figure 4. Diabetes Segment Held Largest Share of Digital Therapeutics Market by Application
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. Digital Therapeutics Market, by Geography (US$ Million)
Figure 7. Global Digital Therapeutics Market - Leading Country Markets (US$ Million)
Figure 8. Global Digital Therapeutics Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East and Africa: PEST Analysis
Figure 13. South and Central America: PEST Analysis
Figure 14. Expert Opinion
Figure 15. Digital Therapeutics market impact analysis of driver and restraints
Figure 16. Global Digital Therapeutics Market - Revenue Forecast and Analysis - 2021 - 2028
Figure 17. Global Digital Therapeutics Market - By Geography Forecast and Analysis - 2021- 2028
Figure 18. Market Positioning of Key Players in Global Digital Therapeutics Market
Figure 19. Digital Therapeutics Market Revenue Share, by Application (2021 and 2028)
Figure 20. Diabetes: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Cardiovascular Disease: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. Central Nervous System Diseases: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. Respiratory Diseases: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. Smoking Cessation: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 25. Musculoskeletal Disorders: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 26. Others: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 27. Digital Therapeutics Market Revenue Share, by Distribution Channel (2021 and 2028)
Figure 28. Patients: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 29. Providers: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. Payers: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 31. Employers: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 32. North America: Digital Therapeutics Market, by Key Country - Revenue (2021) (US$ Million)
Figure 33. North America Digital Therapeutics Market Revenue and Forecast to 2028 (US$ Million)
Figure 34. North America: Digital Therapeutics Market, by Country, 2021 & 2028 (%)
Figure 35. US: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 36. Canada: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 37. Mexico: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 38. Europe: Digital Therapeutics Market, by Key Country - Revenue (2021) (US$ Million)
Figure 39. Europe: Digital Therapeutics Market Revenue and Forecast to 2028 (US$ Million)
Figure 40. Europe: Digital Therapeutics Market, by Country, 2021 & 2028 (%)
Figure 41. Germany: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 42. France: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 43. UK: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 44. Italy: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 45. Spain: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 46. Rest of Europe: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 47. Asia Pacific Digital Therapeutics Market Overview, by Country (2021)
Figure 48. Asia Pacific: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 49. Asia Pacific: Digital Therapeutics Market Revenue and Forecasts to 2028, By Country (%)
Figure 50. Japan: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 51. China: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 52. India: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 53. South Korea: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 54. Australia: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 55. Rest of Asia Pacific: Digital Therapeutics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 56. Middle East & Africa Digital Therapeutics Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 57. Middle East & Africa Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 58. Middle East & Africa Digital Therapeutics Market Revenue and Forecasts to 2028, By Country (%)
Figure 59. UAE: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 60. Saudi Arabia: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 61. South Africa: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 62. Rest of Middle East and Africa: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 63. South and Central America Digital Therapeutics Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 64. South and Central America Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 65. South and Central America Digital Therapeutics Market Revenue and Forecasts to 2028, By Country (%)
Figure 66. Argentina Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 67. Brazil: Digital Therapeutics Market Revenue and Forecasts to 2028 (US$ Million)
Figure 68. Rest of South and Central America: Digital Therapeutics Market - Revenue and Forecast to 2028 (USD Mn)
Figure 69. Impact of COVID-19 Pandemic in North American Country Markets
Figure 70. Impact of COVID-19 Pandemic in European Country Markets
Figure 71. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 72. Impact of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 73. Impact Of COVID-19 Pandemic in South and Central America Africa Country Markets
Companies Mentioned
- Propeller Health
- Canary Health
- NOOM, INC.
- 2MORROW, INC.
- Teladoc Health
- Welldoc, Inc.
- FITBIT, INC.
- OMADA Health
- Mango Health
- Pear Therapeutics, Inc.
- HAPPIFY Health.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 165 |
| Published | February 2022 |
| Forecast Period | 2021 - 2028 |
| Estimated Market Value ( USD | $ 4226.94 million |
| Forecasted Market Value ( USD | $ 18061.79 million |
| Compound Annual Growth Rate | 23.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |
